Autism, inflammatory bowel disease, and MMR vaccine
Walker, D.R.
Lancet 351(9112): 1355; Author Reply 1356
1998
ISSN/ISBN: 0140-6736 PMID: 9643815 Document Number: 490575
Document emailed within 1 workday
Related Documents
Blake, J.; Hoyme, H.E.; Crotwell, P.L. 2013: A brief history of autism, the autism/vaccine hypothesis and a review of the genetic basis of autism spectrum disorders South Dakota Medicine: the Journal of the South Dakota State Medical Association Spec No: 58-65Weiss, D.J.; Gagne, J.M.; Armstrong, P.J. 1996: Relationship between inflammatory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats Journal of the American Veterinary Medical Association 209(6): 1114-1116
Silberer, H.; Küppers, B.; Mickisch, O.; Baniewicz, W.; Drescher, M.; Traber, L.; Kempf, A.; Schmidt-Gayk, H. 2005: Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome Clinical Laboratory 51(3-4): 117-126
Walker, E.A.; Katon, W.J.; Roy-Byrne, P.P.; Jemelka, R.P.; Russo, J. 1993: Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease American Journal of Psychiatry 150(10): 1502-1506
Brullet, E.; Bonfill, X.; Urrútia, G.; Ruiz Ochoa, V.; Cueto, M.; Clofent, J.; Martínez Salmerón, J.F.; Riera, J.; Obrador, A. 1998: Epidemiological study on the incidence of inflammatory bowel disease in 4 Spanish areas. Spanish Group on the Epidemiological Study of Inflammatory Bowel Disease Medicina Clinica 110(17): 651-656
Veljaca, M. 2001: Anti-inflammatory peptides and proteins in inflammatory bowel disease Current Opinion in Investigational Drugs 2(10): 1387-1394
Kirsner, J.B. 1999: "Nonspecific" inflammatory bowel disease (ulcerative colitis and Crohn's disease) after 100 years--what next? Italian Journal of Gastroenterology and Hepatology 31(8): 651-658
Akolkar, P.N.; Gulwani-Akolkar, B.; Heresbach, D.; Lin, X.Y.; Fisher, S.; Katz, S.; Silver, J. 1997: Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease American Journal of Gastroenterology 92(12): 2241-2244
Becker, K.; Niederau, C.; Frieling, T. 1999: Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease Zeitschrift für Gastroenterologie 37(7): 597-605
Krawiec, P.; Pawłowska-Kamieniak, A.; Pac-Kożuchowska, E.żb.; Mroczkowska-Juchkiewcz, A.; Kominek, K. 2016: Coexistence of coeliac disease and inflammatory bowel disease in children Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 40(235): 53-55
García López, S. 2008: Inflammatory bowel disease. If a patient with Crohn's disease remains in remission for 4 years with azathioprine (or mercaptopurine), should the drug be withdrawn? Gastroenterologia y Hepatologia 31(10): 704-705
López San Román, A.; Garrido, E. 2015: Steroids in inflammatory bowel disease Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 107(9): 573
Stenson, W.F.; MacDermott, R.P. 1989: Immunology of inflammatory bowel disease Year in Immunology 4: 286-295
Hovdenak, N.; Schlichting, E. 1998: Inflammatory bowel disease and pregnancy Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(8): 1201-1203
Janowitz, H.D. 2000: Inflammatory bowel disease after 1932 Mount Sinai Journal of Medicine new York 67(3): 190-197
Geboes, K.; Bossaert, H.; Dooms, M.T. 1980: HDL-cholesterol in inflammatory bowel disease Acta Clinica Belgica 35(2): 114-115
Manser, W.W. 1990: Management of inflammatory bowel disease JPMA. Journal of the Pakistan Medical Association 40(11): 279
Asimakopoulos, G. 2004: Pregnancy and inflammatory bowel disease Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(1): 46-50
Malhotra, V.; Narula, N. 1989: Dysplasia in inflammatory bowel disease American Journal of Gastroenterology 84(5): 576-577
Kmieć, Z. 1998: Cytokines in inflammatory bowel disease Archivum Immunologiae et Therapiae Experimentalis 46(3): 143-155